Study Stopped
Previous PI left, staffing changes especially in setting of COVID pandemic meant we no longer wanted to proceed with further recruitment. There were no adverse events or concerns leading to the termination of the study. Simply logistical concerns
Interstitial Cystitis (IC)-Like Findings With Hydrodistension
Correlation Between Urinary Symptoms and Interstitial Cystitis (IC)-Like Findings on Cystoscopy With Hydrodistension
1 other identifier
observational
734
1 country
1
Brief Summary
Patients who are already scheduled to have a gynecologic, urologic or uro-gynecologic procedure involving cystoscopy (a lighted scope is used to look inside the bladder) under anesthesia will be approached to participate in the study. Once prospective study subjects are consented, they will be requested to complete the study questionnaires. At the time of the procedure, during the cystoscopy, patients will undergo hydrodistension (stretching the bladder with fluid). Photographic images of the bladder will be collected, to be later analyzed by examiners. Patients who have positive findings for interstitial cystitis during cystoscopy with hydrodistension, will be notified of the findings after the procedure. They will be asked to fill out an additional, previously completed questionnaire at the time of a follow-up visit, during a phone interview or responding to the questionnaire via a secure web site. These patients will be treated for interstitial cystitis by their primary providers as clinically indicated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2015
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2015
CompletedFirst Submitted
Initial submission to the registry
August 26, 2015
CompletedFirst Posted
Study publicly available on registry
September 11, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 18, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
January 18, 2018
CompletedJanuary 26, 2022
January 1, 2022
2.6 years
August 26, 2015
January 11, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Correlation between severity of urinary symptoms and IC-like findings on cystoscopy with hydrodistension.
Change From Baseline in Pain on the 11 point Short Pain Scale (SPS-11).
up to 5 years
Secondary Outcomes (7)
The association of GI symptoms with IC-like findings on cystoscopy with hydrodistension
up to 5 years
The correlation between O'Leary-Sant score and cystoscopic findings
up to 5 years
The correlation between PUF score and cystoscopic findings
up to 5 years
The association between cystoscopic and previous urologic or gynecologic surgeries
up to 5 years
The number of patients with interstitial cystitis who's symptoms improve after cystoscopy with hydrodistension
up to 5 years
- +2 more secondary outcomes
Study Arms (1)
All participants
All participants will be filling out questionnaires and undergoing cystoscopy with hydrodistension for evaluative reasons
Eligibility Criteria
All women scheduled to undergo cystoscopy or cystoscopy with hydrodistension in an academic institution, within the benign gynecologic division with eligibility criteria as above.
You may qualify if:
- Female
- Patients must be at least 18 years of age.
- Patients must have been previously scheduled for a surgical procedure that includes cystoscopy under anesthesia or cystoscopy with hydrodistension under anesthesia.
- Patients must be able to provide written informed consent.
You may not qualify if:
- pregnancy
- planned cystotomy
- incidental cystotomy during surgery - patient not eligible for hydrodistention
- patient's age \> 90
- history of pelvic radiation 6, Previous or newly diagnosed bladder tumor
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
St. Mary's Health Center
St Louis, Missouri, 63117, United States
Biospecimen
Urine samples retained
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ioana Marcu, MD
St. Louis University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
August 26, 2015
First Posted
September 11, 2015
Study Start
June 1, 2015
Primary Completion
January 18, 2018
Study Completion
January 18, 2018
Last Updated
January 26, 2022
Record last verified: 2022-01
Data Sharing
- IPD Sharing
- Will not share